In a laboratory mouse model study, Colombo et al. researched epilepsy caused by GNB1 mutation Lys78Arg, which is close to the patient’s mutation (Asp76Asn), and reached promising results in using the GIRK channel blocker ethosuximide [12]. Here, GNB1 is linked to epilepsy.